Skip to content

Impact of Preoperative 3D Printed Stoma Placement on the Quality of Life of Ostomy Patients

Impact of Preoperative 3D Printed Stoma Placement on the Quality of Life of Ostomy Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04326335
Acronym
Stomie 3D
Enrollment
50
Registered
2020-03-30
Start date
2020-07-29
Completion date
2024-08-12
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ostomy

Brief summary

The making of an ostomy in patients is experienced as traumatic. The stoma changes body image, self-esteem and is responsible for increased anxiety. These changes affect the quality of life of patients. To reduce the negative impact of the stoma, patients are seen in preoperative consultation by the stoma nurses. This consultation allows to show the patients the appearance of a stoma (through a photograph), the equipment used and how it works. In 2016, McKenna et al. showed the interest of marking (with felt pen) the ostomy site on the abdomen in preoperative. In this study, patients with preoperative marking had a higher post-operative quality of life score than patients without marking (p=0.03). Quality of life was assessed using the STOMA-QOL score. This quality of life score is specific for ostomy patients. It assesses 4 dimensions: sleep, intimate relationships, relationships with family and close friends, relationships with people other than family and close friends. This questionnaire includes 20 questions and has been validated in 5 languages including French. The aim of this pilot study is to evaluate the post-operative quality of life of ostomy patients who have benefited from a preoperative therapeutic education session with the placement of the 3D printed ostomy button versus felt-tip marking, during the 15 days prior to the operation.

Interventions

OTHERFelt-tip marking

Marking the location of the future stoma with a felt pen

OTHERFelt-tip marking + 3D printed ostomy button

Marking the location of the future stoma with a felt pen + 3D printed ostomy button placed on the future stoma location

Sponsors

Centre Hospitalier Departemental Vendee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient ≥ 18 years old, * First ileostomy with indication for temporary stoma placement, * Patient with scheduled surgery, * Patient who has the capacity to understand the protocol and has given consent to participate in the research, * Patient with social security coverage.

Exclusion criteria

* Patient \< 18 years old, * Patient with an indication for placement of a permanent stoma, * Emergency surgery patient, * Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception, * Patient under guardianship, curators or legal protection, * Patient participating in another interventional clinical research protocol involving a drug or medical device.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the Post-operative Quality of Life of Ostomy Patients Having Benefited From Preoperative Therapeutic Education Sessions With 3D Printed Ostomy Button Placement Versus Felt Marking.2 months post-discharge, up to 3 monthsTotal score on the Stoma-QOL (Quality-Of-Life) questionnaire The points obtained for each of the 20 questions are added together to obtain an overall score. This raw summary score per patient in the 20-80 range will be converted into a final score "0-100 score" where 0 indicates the worst Quality of Life and 100 the best Quality of Life.

Countries

France

Contacts

PRINCIPAL_INVESTIGATOREmeric ABET

Centre Hospitalier Departemental Vendee

Baseline characteristics

Characteristic
Age, Continuous64 years
STANDARD_DEVIATION 15
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
France
25 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026